Hyundai Bioscience

048410.KQ

9.37 USD

-0.20

-2.09%

Overview

Last close

9.37 usd

Market cap

900.04M usd

52 week high

13.86 usd

52 week low

3.13 usd

Target price

N/A usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

379.5274

Price/Book Value

12.0562

Enterprise Value

884.07M usd

EV/Revenue

373.1895

EV/EBITDA

-64.6317

Key financials

Revenue TTM

2.37M usd

Gross Profit TTM

-1136.96 usd

EBITDA TTM

-11.35M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

90.62M usd

Net debt

N/A usd

About

Hyundai Bioscience Co., Ltd. operates as a biotechnology company. The company provides Vitabrid C12, a vitamin C product that delivers active vitamin C into the skin. It develops Polytaxel, a drug for pancreatic cancer and solid tumors; and CP-COV03 drug for Covid 19. The company was founded in 2000 and is based in Seoul, South Korea.